![John Sunwoo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Sunwoo
Nessuna posizione attualmente
Profilo
John Sunwoo is the founder of Indapta Therapeutics, Inc. which was founded in 2017.
He holds a doctorate degree from Stanford University.
Precedenti posizioni note di John Sunwoo
Società | Posizione | Fine |
---|---|---|
Indapta Therapeutics, Inc.
![]() Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Fondatore | - |
Formazione di John Sunwoo
Stanford University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Indapta Therapeutics, Inc.
![]() Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Health Technology |
- Borsa valori
- Insiders
- John Sunwoo